In addition to the above, given that COVID-19 is a viral infection, the role of CD8+ T cells has been examined and found to be protective, and it may be even more important in patients with hematological malignancies who have impaired humoral responses [152,153]. The gene discussed is CD8A; the disease is COVID-19.